Tag Archives: Valsartan
-
-
Valsartan Problems Lead Regulators to Look for NDMA, Other Cancer-Causing Impurities, In Other Drugs
-
Valsartan Lawsuit Seeks Class Action Status Over Recalled Pills
-
Valsartan Problems Continue, With Identification of Second Cancer-Causing Impurity
-
Valsartan NDMA Cancer Risks Evaluated in New Study
-
Valsartan Recall Lawsuit Filed Against Generic Drug Makers
-
Valsartan Testing by FDA Officials May Lead to More Recalls for Blood Pressure Drug
-
Valsartan NDMA Cancer-Causing Impurity Results in Recall Expansion
-
Valsartan Class Action Lawsuit Filed Against Manufacturers Over Cancer Risks
-
Generic Valsartan Recall Expanded Again, After Cancer-Causing Ingredient Found in Pills from Another Manufacturer